Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

MicroRNA profiling of activated and tolerogenic human dendritic cells.

Stumpfova Z, Hezova R, Meli AC, Slaby O, Michalek J.

Mediators Inflamm. 2014;2014:259689. doi: 10.1155/2014/259689. Epub 2014 Apr 1.

PMID:
24799764
[PubMed - in process]
Free PMC Article
2.

[The role of microRNAs in molecular pathology of esophageal cancer and their potential usage in clinical oncology].

Kovaříková A, Héžová R, Srovnal J, Rédová-Lojová M, Slabý O.

Klin Onkol. 2014;27(2):87-96. Czech.

PMID:
24739044
[PubMed - in process]
3.

MicroRNA-206: a promising theranostic marker.

Novák J, Kružliak P, Bienertová-Vašků J, Slabý O, Novák M.

Theranostics. 2014 Jan 2;4(2):119-33. doi: 10.7150/thno.7552. eCollection 2014.

PMID:
24465270
[PubMed - in process]
Free PMC Article
4.

Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.

Kubiczkova L, Kryukov F, Slaby O, Dementyeva E, Jarkovsky J, Nekvindova J, Radova L, Greslikova H, Kuglik P, Vetesnikova E, Pour L, Adam Z, Sevcikova S, Hajek R.

Haematologica. 2014 Mar;99(3):511-8. doi: 10.3324/haematol.2013.093500. Epub 2013 Nov 15.

PMID:
24241494
[PubMed - in process]
Free PMC Article
5.

Urine microRNAs as potential noninvasive biomarkers in urologic cancers.

Mlcochova H, Hezova R, Stanik M, Slaby O.

Urol Oncol. 2014 Jan;32(1):41.e1-9. doi: 10.1016/j.urolonc.2013.04.011. Epub 2013 Sep 10.

PMID:
24035473
[PubMed - in process]
6.

MicroRNAs targeting EGFR signalling pathway in colorectal cancer.

Mlcochova J, Faltejskova P, Nemecek R, Svoboda M, Slaby O.

J Cancer Res Clin Oncol. 2013 Oct;139(10):1615-24. doi: 10.1007/s00432-013-1470-9. Epub 2013 Jul 2. Review.

PMID:
23817698
[PubMed - indexed for MEDLINE]
7.

MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis.

Novák J, Vinklárek J, Bienertová-Vašků J, Slabý O.

Pediatr Blood Cancer. 2013 Nov;60(11):1739-46. doi: 10.1002/pbc.24664. Epub 2013 Jun 27. Review. Erratum in: Pediatr Blood Cancer. 2014 Feb;61(2):390.

PMID:
23813576
[PubMed - indexed for MEDLINE]
8.

Extension of microRNA expression pattern associated with high-risk neuroblastoma.

Bienertova-Vasku J, Mazanek P, Hezova R, Curdova A, Nekvindova J, Kren L, Sterba J, Slaby O.

Tumour Biol. 2013 Aug;34(4):2315-9. doi: 10.1007/s13277-013-0777-0. Epub 2013 Jun 20.

PMID:
23784455
[PubMed - indexed for MEDLINE]
9.

[Epidemiological and clinico-pathological characteristics of patients with renal carcinoma: a single institution analysis of 544 cases].

Poprach A, Lakomý R, Selingerová I, Dolečková B, Bílek O, Slabý O, Héžová R, Fabian P, Staník M, Pavlík T, Bortlíček Z, Mlčochová H, Tkáč D, Vyzula R, Kiss I, Kocák I, Kocáková I, Svoboda M.

Klin Onkol. 2013;26(2):114-23. Czech.

PMID:
23718670
[PubMed - indexed for MEDLINE]
10.

The role of microRNAs in mitochondria in cancer.

Bienertova-Vasku J, Sana J, Slaby O.

Cancer Lett. 2013 Aug 9;336(1):1-7. doi: 10.1016/j.canlet.2013.05.001. Epub 2013 May 9. Review.

PMID:
23665507
[PubMed - indexed for MEDLINE]
11.

MicroRNAs involved in chemo- and radioresistance of high-grade gliomas.

Besse A, Sana J, Fadrus P, Slaby O.

Tumour Biol. 2013 Aug;34(4):1969-78. doi: 10.1007/s13277-013-0772-5. Epub 2013 Apr 9. Review.

PMID:
23568705
[PubMed - indexed for MEDLINE]
12.

Circulating miRNAs as new blood-based biomarkers for solid cancers.

Redova M, Sana J, Slaby O.

Future Oncol. 2013 Mar;9(3):387-402. doi: 10.2217/fon.12.192. Review.

PMID:
23469974
[PubMed - indexed for MEDLINE]
13.

Identification of microRNAs regulated by isothiocyanates and association of polymorphisms inside their target sites with risk of sporadic colorectal cancer.

Slaby O, Sachlova M, Brezkova V, Hezova R, Kovarikova A, Bischofová S, Sevcikova S, Bienertova-Vasku J, Vasku A, Svoboda M, Vyzula R.

Nutr Cancer. 2013;65(2):247-54. doi: 10.1080/01635581.2013.756530.

PMID:
23441612
[PubMed - indexed for MEDLINE]
14.

MiR-190 leads to aggressive phenotype of neuroblastoma through indirect activation of TrkB pathway.

Slaby O.

Med Hypotheses. 2013 Mar;80(3):325-6. doi: 10.1016/j.mehy.2012.11.033. Epub 2012 Dec 11. No abstract available.

PMID:
23245204
[PubMed - indexed for MEDLINE]
15.

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.

Svoboda M, Sana J, Fabian P, Kocakova I, Gombosova J, Nekvindova J, Radova L, Vyzula R, Slaby O.

Radiat Oncol. 2012 Nov 20;7:195. doi: 10.1186/1748-717X-7-195.

PMID:
23167930
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.

Redova M, Poprach A, Besse A, Iliev R, Nekvindova J, Lakomy R, Radova L, Svoboda M, Dolezel J, Vyzula R, Slaby O.

Tumour Biol. 2013 Feb;34(1):481-91. doi: 10.1007/s13277-012-0573-2. Epub 2012 Nov 13.

PMID:
23150176
[PubMed - indexed for MEDLINE]
17.

[Long non-coding RNAs and their relevance in cancer].

Sána J, Faltejsková P, Svoboda M, Slabý O.

Klin Onkol. 2012;25(4):246-54. Review. Czech.

PMID:
22920164
[PubMed - indexed for MEDLINE]
18.

Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab.

Grell P, Fabian P, Khoylou M, Radova L, Slaby O, Hrstka R, Vyzula R, Hajduch M, Svoboda M.

Int J Oncol. 2012 Oct;41(4):1204-12. doi: 10.3892/ijo.2012.1576. Epub 2012 Jul 27.

PMID:
22842582
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[Triple-negative breast cancer: analysis of patients diagnosed and/or treated at the Masaryk Memorial Cancer Institute between 2004 and 2009].

Svoboda M, Navrátil J, Fabian P, Palácová M, Gombošová J, Slámová L, Princ D, Syptáková B, Kudláček A, Bílek O, Pospíšil P, Kazda T, Grell P, Poprach A, Selingerová I, Nenutil R, Juráček J, Héžová R, Slabý O, Vyzula R.

Klin Onkol. 2012;25(3):188-98. Czech. Erratum in: Klin Onkol. 2013;26(2):139.

PMID:
22724568
[PubMed - indexed for MEDLINE]
20.

Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer.

Hezova R, Kovarikova A, Bienertova-Vasku J, Sachlova M, Redova M, Vasku A, Svoboda M, Radova L, Kiss I, Vyzula R, Slaby O.

World J Gastroenterol. 2012 Jun 14;18(22):2827-31. doi: 10.3748/wjg.v18.i22.2827.

PMID:
22719192
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk